Abbott Laboratories (ABT)

ABT (NYSE:Health Services) EQUITY
$49.08
pos +0.00
+0.00%
Today's Range: 48.97 - 49.36 | ABT Avg Daily Volume: 6,761,800
Last Update: 06/23/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 27.78%
Open: $0.00
Previous Close: $49.27
52 Week Range: $36.76 - $49.59
Oustanding Shares: 1,735,272,054
Market Cap: 85,496,854,101
6-Month Chart
TheStreet Ratings Grade for ABT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 10 9 9 9
Moderate Buy 2 2 2 2
Hold 4 4 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.63 1.67 1.75 1.75
Latest Dividend: 0.26
Latest Dividend Yield: 2.15%
Dividend Ex-Date: 07/12/17
Price Earnings Ratio: 55.36
Price Earnings Comparisons:
ABT Sector Avg. S&P 500
55.36 50.80 30.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.63% 23.85% 20.50%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.20 -0.10 -0.02
Net Income -68.30 -0.60 -0.23
EPS -67.80 -0.40 -0.17
Earnings for ABT:
EBITDA 4.70B
Revenue 20.85B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $0.60 $0.66 $2.47 $2.78
Number of Analysts 10 8 13 12
High Estimate $0.61 $0.69 $2.52 $2.86
Low Estimate $0.60 $0.64 $2.44 $2.70
Prior Year $0.55 $0.59 $2.20 $2.47
Growth Rate (Year over Year) 9.82% 12.29% 12.27% 12.42%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
A rotation that started as the minor chord of the rotational symphony and is now the major one.
Barring a close below $46, we are likely to see ABT remain firm and work higher.
We really want to shake out the weak hands here.
It's a wonder to me how split this market really is.
Medtronic, Abbott Labs and Becton Dickinson appear to be offering buying opportunities.
These charts are showing bullish or bearish reversals.
Their overseas business has been carrying them.
We know that we are in the era when index managers are ascendant.
Here are the levels to watch and act on.
Bearish
Mar 14, 2017 | 7:26 AM EDT
ABT was downgraded from Outperform to Market Perform, BMO Capital said. $48 price target. Valuation call, as the stock is up 19% year-t...

Columnist Conversations

we still like this trade but need some more time on it. SOLD WDC JUL 87.5 CALL AT 5.40 (in at 5.85) BOUG...
Impinj ( $PI) is still forming a bull flag. Holding up just fine, and 27% of float is short. This is a powe...
stellar numbers and the stock continues to attract buyers, it's now in the fat tail and this could go for a fe...
General Electric's outgoing CEO Jeff Immelt had some choice things to say at an event in NYC on Thursday ...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.